A radioactive assay for acetylcholinesterase using anion-exchange disk
β Scribed by Richard K. Gordon; B.P. Doctor; Peter K. Chiang
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 321 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
β¦ Synopsis
A radioactive assay for acetylcholinesterase is described. The assay is based on the separation of [%]acetate from ["C]acetylcholine by differential adsorption of the former on DEAE anion-exchange disks. The procedure is simple and sensitive and eliminates the use of ionexchange resin columns or organic extractions. Moreover, when unpurified enzyme preparations are assayed, linear steady-state kinetics can be observed with this method as contrasted to the nonlinear calorimetric method using acetylthiocholine and dithiobisnitrobenzoate. This method also permits the detection in biological samples of low levels of acetylcholinesterase activity, which is not detectable by the calorimetric method. Using the present radioactive method, cellular levels of acetylcholinesterase have been surveyed in N4TGl neuroblastoma cells, NG108-15 neuroblastoma x glioma hybrid cells, H9c2 myoblasts, and 3T3-Ll and 3T3-C2 fibroblasts.
π SIMILAR VOLUMES
A polymerase chain reaction (PCR)-based radioactive telomerase assay was developed in our laboratory which is quantitative and does not require electrophoretic evaluation (designated as TP-TRAP; it utilizes two reverse primers). The main steps of the assay include (1) extension of a 20-mer oligonucl
Anion exchange high performance liquid chromatography (AX-HPLC) has been widely used for separating and quantifying various haemoglobin fractions especially in the haemoglobinopathies. We have evaluated the reliability of this technique to measure low concentrations of adult haemoglobin (HbA) in fet
Ongoing and extensive screening for potentially selective and potent inhibitors of RNA-dependent DNA polymerases (reverse transcriptases) is important for the discovery of therapeutic agents active against retroviruses. lkaditional systems for assaying the activity of reverse transcriptase enzymes h